C07K 5/1021
With the first amino acid being acidic
Official title: {with the first amino acid being acidic}
C07K5/1021 (With the first amino acid being acidic) appears on 376 US grants and 438 published applications in this corpus.
Search patents in C07K- Granted patents
- 376
- Published applications
- 438
- Assignees
- 311
- Inventors
- 1,006
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 10 | 0 |
| 2000 | 15 | 0 |
| 2001 | 12 | 1 |
| 2002 | 9 | 12 |
| 2003 | 11 | 19 |
| 2004 | 8 | 20 |
| 2005 | 9 | 20 |
| 2006 | 17 | 20 |
| 2007 | 12 | 17 |
| 2008 | 6 | 14 |
| 2009 | 16 | 20 |
| 2010 | 13 | 28 |
| 2011 | 9 | 19 |
| 2012 | 10 | 14 |
| 2013 | 20 | 20 |
| 2014 | 17 | 26 |
| 2015 | 11 | 13 |
| 2016 | 21 | 17 |
| 2017 | 12 | 16 |
| 2018 | 12 | 20 |
| 2019 | 3 | 12 |
| 2020 | 14 | 14 |
| 2021 | 6 | 12 |
| 2022 | 4 | 13 |
| 2023 | 9 | 16 |
| 2024 | 11 | 21 |
| 2025 | 11 | 19 |
| 2026 | 6 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Aqueous peptide programming of the vinylidene fluoride ferroelectric phase29 Sep 2026US 12,747,302 B2Northwestern University
- Preparation method, intermediates, and use of cyclic peptide toxin alpha-amanitin and/or amaninamide1 Sep 2026US 12,723,060 B2Inner Mongolia Duhe Innovation R & D Tech Co., Ltd
- Tetrapeptide and compositions comprising tetrapeptides7 Apr 2026US 12,594,227 B2The Boots Company PLC
- Compounds and methods for treating cancer, viral infections, and allergic conditions31 Mar 2026US 12,590,123 B2Washington University
- Compositions and methods for purifying biological fluids6 Aug 2026US 2026/0225001 A1
- Peptides for incretin synthesis6 Aug 2026US 2026/0226102 A1Eli Lilly and Company
- Peptides for incretin synthesis30 Jul 2026US 2026/0217762 A1Eli Lilly and Company
- Peptide inhibiting formation of snare complexes, and cosmetic composition containing same16 Jul 2026US 2026/0200973 A1Supadelixir Inc.
- Peptide for cartilage regeneration, and uses thereof16 Jul 2026US 2026/0200975 A1Caregen Co., Ltd.
Most cited
By later US patents
- Intracellular delivery of biological effectors115US 6,960,648 B2Universite de Lausanne · 2005
- Tetrapyrrole therapeutic agents113US 4,675,338 ANippon Petrochemicals Company, Limited · 1987
- Synthetic peptide inhibitors of HIV transmission102US 5,464,933 ADuke University · 1995
- Cyclic cell adhesion modulation compounds101US 5,192,746 ATanabe Seiyaku Co., Ltd. · 1993
- Method of blocking immune complex binding to immunoglobulin FC receptors99US 4,752,601 AImmunetech Pharmaceuticals · 1988